These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 11260486

  • 1. Tacrolimus: the good, the bad, and the ugly.
    Chand DH, Southerland SM, Cunningham RJ.
    Pediatr Transplant; 2001 Feb; 5(1):32-6. PubMed ID: 11260486
    [Abstract] [Full Text] [Related]

  • 2. Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus.
    Cao S, Cox KL, Berquist W, Hayashi M, Concepcion W, Hammes GB, Ojogho OK, So SK, Frerker M, Castillo RO, Monge H, Esquivel CO.
    Pediatr Transplant; 1999 Feb; 3(1):22-6. PubMed ID: 10359027
    [Abstract] [Full Text] [Related]

  • 3. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE, Gohh R, Shaffer D, Crosson A, Madras PN, Sahyoun AI, Monaco AP.
    Transplantation; 1997 Mar 27; 63(6):845-8. PubMed ID: 9089224
    [Abstract] [Full Text] [Related]

  • 4. Pediatric renal transplantation under tacrolimus-based immunosuppression.
    Shapiro R, Scantlebury VP, Jordan ML, Vivas C, Ellis D, Lombardozzi-Lane S, Gilboa N, Gritsch HA, Irish W, McCauley J, Fung JJ, Hakala TR, Simmons RL, Starzl TE.
    Transplantation; 1999 Jan 27; 67(2):299-303. PubMed ID: 10075598
    [Abstract] [Full Text] [Related]

  • 5. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug 27; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 6. Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
    Chakrabarti P, Wong HY, Scantlebury VP, Jordan ML, Vivas C, Ellis D, Lombardozzi-Lane S, Hakala TR, Fung JJ, Simmons RL, Starzl TE, Shapiro R.
    Transplantation; 2000 Sep 15; 70(5):760-4. PubMed ID: 11003353
    [Abstract] [Full Text] [Related]

  • 7. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients.
    McKee M, Segev D, Wise B, Case B, Neu A, Fivush B, Colombani P.
    J Pediatr Surg; 1997 May 15; 32(5):688-90. PubMed ID: 9165452
    [Abstract] [Full Text] [Related]

  • 8. Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus.
    Sokal EM, Antunes H, Beguin C, Bodeus M, Wallemacq P, de Ville de Goyet J, Reding R, Janssen M, Buts JP, Otte JB.
    Transplantation; 1997 Nov 27; 64(10):1438-42. PubMed ID: 9392308
    [Abstract] [Full Text] [Related]

  • 9. Protocol biopsies in pediatric renal transplant recipients on cyclosporine versus tacrolimus-based immunosuppression.
    Aoun B, Decramer S, Vitkevic R, Wannous H, Bandin F, Azema C, Callard P, Brocheriou I, Ulinski T.
    Pediatr Nephrol; 2013 Mar 27; 28(3):493-8. PubMed ID: 23111894
    [Abstract] [Full Text] [Related]

  • 10. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.
    Transpl Immunol; 2008 Nov 27; 20(1-2):32-42. PubMed ID: 18773960
    [Abstract] [Full Text] [Related]

  • 11. A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group.
    Woodle ES, Thistlethwaite JR, Gordon JH, Laskow D, Deierhoi MH, Burdick J, Pirsch JD, Sollinger H, Vincenti F, Burrows L, Schwartz B, Danovitch GM, Wilkinson AH, Shaffer D, Simpson MA, Freeman RB, Rohrer RJ, Mendez R, Aswad S, Munn SR, Wiesner RH, Delmonico FL, Neylan J, Whelchel J.
    Transplantation; 1996 Sep 15; 62(5):594-9. PubMed ID: 8830821
    [Abstract] [Full Text] [Related]

  • 12. Increased early rejection rate after conversion from tacrolimus in kidney and pancreas transplantation.
    Barone GW, Ketel BL, Abul-Ezz SR, Lightfoot ML.
    JOP; 2002 Mar 15; 3(2):49-53. PubMed ID: 11884766
    [Abstract] [Full Text] [Related]

  • 13. One-year results of basiliximab induction and tacrolimus associated with sequential steroid and MMF treatment in pediatric kidney transplant recipient.
    Montini G, Murer L, Ghio L, Pietrobon B, Ginevri F, Ferraresso M, Cardillo M, Scalamogna M, Perfumo F, Edefonti A, Zanon GF, Zacchello G.
    Transpl Int; 2005 Jan 15; 18(1):36-42. PubMed ID: 15612981
    [Abstract] [Full Text] [Related]

  • 14. Initial experience with tacrolimus rescue therapy in OKT3 resistant rejection.
    Herget S, Heemann U, Friedrich J, Kribben A, Wagner K, Philipp T.
    Clin Nephrol; 1996 May 15; 45(5):352-4. PubMed ID: 8738671
    [Abstract] [Full Text] [Related]

  • 15. Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection.
    Reyes J, Jain A, Mazariegos G, Kashyap R, Green M, Iurlano K, Fung J.
    Transplantation; 2000 Jun 27; 69(12):2573-80. PubMed ID: 10910279
    [Abstract] [Full Text] [Related]

  • 16. Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients.
    Sampaio MS, Cho YW, Shah T, Bunnapradist S, Hutchinson IV.
    Transplantation; 2012 Jan 15; 93(1):73-81. PubMed ID: 22129761
    [Abstract] [Full Text] [Related]

  • 17. Tacrolimus in pediatric renal transplantation: a review.
    Shapiro R.
    Pediatr Transplant; 1998 Nov 15; 2(4):270-6. PubMed ID: 10084728
    [Abstract] [Full Text] [Related]

  • 18. Tacrolimus: a further update of its use in the management of organ transplantation.
    Scott LJ, McKeage K, Keam SJ, Plosker GL.
    Drugs; 2003 Nov 15; 63(12):1247-97. PubMed ID: 12790696
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May 15; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 20. Tacrolimus monotherapy in adult cardiac transplant recipients: intermediate-term results.
    Baran DA, Segura L, Kushwaha S, Courtney M, Correa R, Fallon JT, Cheng J, Lansman SL, Gass AL.
    J Heart Lung Transplant; 2001 Jan 15; 20(1):59-70. PubMed ID: 11166613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.